Painimation: An innovative, technology-based method for measuring pain quality, location and severity in sickle cell disease

Painimation：一种基于技术的创新方法，用于测量镰状细胞病的疼痛质量、位置和严重程度

• 批准号: 9649363
• 负责人: Charles Richard Jonassaint
• 金额: $ 7.83万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-15 至 2020-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9649363
• 关键词: Acute; Adult; Behavior Therapy; Brief Pain Inventory; Car Phone; Caring; Client satisfaction; Clinic; Clinical; Clinical Research; Clinical Trials; Cognitive Therapy; Communication; Complex; Cross-Sectional Studies; Data; Development; Diagnosis; Dimensions; Exhibits; Frustration; Funding; Future; Goals; Health; Healthcare Systems; Image; Intervention; Interview; Location; McGill Pain Scale; Measurement; Measures; Mentored Patient-Oriented Research Career Development Award; Methods; Minority Groups; Mission; National Heart, Lung, and Blood Institute; Neuropathy; Nociception; Numeric Rating Scale; Organ; Outcome; Outcome Measure; Pain; Pain Assessment Tool; Pain Clinics; Pain Measurement; Pain intensity; Pain management; Pain quality; Patient Outcomes Assessments; Patients; Persons; Physicians; Population; Preparation; Provider; Public Health; Quality of life; Reporting; Research; Research Personnel; Sampling; Severities; Sickle Cell Anemia; Technology; Testing; Therapeutic Intervention; Underserved Population; Visit; Visual; Work; analog; animation; base; chronic pain; chronic pain patient; clinical pain; computerized; daily functioning; design; direct patient care; experience; handheld mobile device; health care availability; improved; improved outcome; innovative technologies; literacy; mobile computing; new technology; novel; opioid use; pain outcome; pain perception; patient oriented; patient-clinician communication; primary outcome; symptom management; tool; treatment effect; usability; user centered design

PROJECT ABSTRACT Pain is the number one reason adults with sickle cell disease (SCD) access the healthcare system. To adequately treat pain first requires accurate assessment, however, there are no pain measures that effectively capture the multidimensional phenomenon of SCD pain. One-dimensional measures of pain, such as the numerical 0-10 scale, have limited utility and are ineffective for guiding treatment. Multi-dimensional pain tools are long and complex, making them difficult for patients to use. There have been no attempts to create a multi- dimensional measure to assess and classify pain in SCD. The long-term goal of this project is to develop a comprehensive, patient-centered, pain assessment tool, that will improve patient-provider communication, pain diagnosis, and treatment of pain. The proposed R03 tests a novel electronic pain assessment tool called Painimation, that allows patients to use animations and graphical images to communicate their pain. Our primary objective will be to determine if Painimation is acceptable to patients and can be used as a valid SCD pain assessment tool. We hypothesize that Painimation will be more usable and acceptable to patients than standard scales. In Aim 1, we will determine the usability and acceptability of Painimation for communicating and assessing pain among adults with SCD. We will test Painimation alongside other validated pain scales (the 0-10 visual analog scale, PainDETECT, and the McGill Pain Questionnaire) among 70 adults with SCD in a cross-sectional survey study. For each measure, we will evaluate usability, patient satisfaction, and perceived usefulness for communicating pain to providers. In Aim 2, we will determine whether pain assessment using Painimation is associated with patients' quality of life and clinical outcomes. We will test the association of Painimation with patient-reported quality of life (ASCQ-Me) and objective health outcomes (i.e. organ damage, number of acute care visits for pain) to determine if Painimation is a viable outcome measure in clinical trials testing pain interventions. Finally, in an exploratory Aim 3, we will test whether Painimation can differentiate SCD pain types (e.g. neuropathic vs nociceptive). The proposed research is significant because it will lead to the creation of a brief, accurate, and user-centered pain assessment tool for use in SCD. Our team includes experts in IT, UX design, pain, and measurement development. Expanding Painimation, a novel, technology- based pain assessment tool, for use in SCD directly relates to and results from my K23 project and will advance my potential as an independent investigator to conduct large-scale (R01) studies examining the impact of pain interventions on health outcomes. Long-term, improved outcomes measurement will increase our ability to detect the effects of our mobile technology-delivered behavioral interventions.

项目摘要 疼痛是患有镰状细胞病 (SCD) 的成年人进入医疗保健系统的首要原因。到 充分治疗疼痛首先需要准确的评估，但是目前还没有有效的止痛措施 捕捉 SCD 疼痛的多维现象。一维疼痛测量，例如 0-10 的数值范围，实用性有限，无法有效指导治疗。多维疼痛工具 它们又长又复杂，使患者难以使用。尚未尝试创建多 用于评估和分类 SCD 疼痛的维度测量。该项目的长期目标是开发一个 全面的、以患者为中心的疼痛评估工具，将改善患者与提供者的沟通、疼痛 疼痛的诊断和治疗。拟议的 R03 测试了一种新型电子疼痛评估工具，称为 疼痛动画，允许患者使用动画和图形图像来表达他们的疼痛。我们的 主要目标是确定患者是否可以接受疼痛并可用作有效的 SCD 疼痛评估工具。我们假设 Painimation 比疼痛更容易被患者使用和接受。 标准秤。在目标 1 中，我们将确定 Painimation 用于通信的可用性和可接受性 评估成人 SCD 患者的疼痛。我们将测试 Painimation 以及其他经过验证的疼痛量表（ 0-10 视觉模拟量表、PainDETECT 和麦吉尔疼痛问卷）在 70 名患有 SCD 的成年人中进行 横断面调查研究。对于每项措施，我们将评估可用性、患者满意度和感知度 对于向提供者传达疼痛的有用性。在目标 2 中，我们将确定疼痛评估是否使用 疼痛与患者的生活质量和临床结果相关。我们将测试关联 疼痛与患者报告的生活质量 (ASCQ-Me) 和客观健康结果（即器官损伤、 因疼痛而进行紧急护理的次数），以确定疼痛是否是临床试验中可行的结果衡量标准 测试疼痛干预措施。最后，在探索性目标 3 中，我们将测试 Painimation 是否可以区分 SCD 疼痛类型（例如神经性疼痛与伤害性疼痛）。拟议的研究意义重大，因为它将导致 创建一个简短、准确且以用户为中心的用于 SCD 的疼痛评估工具。我们的团队包括 IT、UX 设计、疼痛和测量开发方面的专家。扩展Painimation，一种新颖的技术 基于疼痛评估工具，用于 SCD 直接与我的 K23 项目相关并产生结果，并将 提高我作为独立研究者的潜力，进行大规模（R01）研究，检查 疼痛干预对健康结果的影响。从长期来看，改进的结果测量将会增加 我们检测移动技术提供的行为干预措施效果的能力。